Andrew Beelen, MD, serves as Vice President of Clinical Development at Incyclix Bio and is an Industry Advisory Board Member at the Eshelman Institute for Innovation, UNC Eshelman School of Pharmacy. Previous roles include Executive Director and Vice President of Clinical Development at G1 Therapeutics, Senior Director of Clinical Development, and Sr. Medical Director focusing on Oncology Medical Strategy & Science at Quintiles. Andrew also held the position of Director of Clinical Research at Actavis. The educational background includes an MD in Medicine from Upstate Medical University (1993-1997) and further studies at the Geisel School of Medicine at Dartmouth (2000-2002).
August, 2024 - present
Vice President Clinical Development at Equillium
Vice President Clinical Development at Bristol-Myers Squibb
Senior Vice President - Clinical Development, Therapeutic Area Head - Pulmonology at 4D Molecular Therapeutics
Vice President, Clinical Development at Omeros
Vice President Clinical Development, Oncology at Dragonfly Therapeutics
Access the worlds's biggest network of public org charts
Learn more